| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000023705 |
| Receipt No. | R000027271 |
| Scientific Title | Transcatheter aortic valve implantation for aortic stenosis registry |
| Date of disclosure of the study information | 2016/08/21 |
| Last modified on | 2020/02/22 (Ver. 9) |
| Basic information | ||
| Public title | Transcatheter aortic valve implantation for aortic stenosis registry | |
| Acronym | AS-TAVI registry | |
| Scientific Title | Transcatheter aortic valve implantation for aortic stenosis registry | |
| Scientific Title:Acronym | AS-TAVI registry | |
| Region |
|
|
| Condition | |||
| Condition | Aortic stenosis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | This registry was initiated to observe and document the course of aortic stenosis, that was considered TAVI as a treatment. Especially for the cases treated by TAVI, we focus on procedural results and post-procedural outcome of TAVI. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Cumulative survival rate after TAVI |
| Key secondary outcomes | Cardiac death after TAVI
Re-admission for heart failure after TAVI Cerebrovascular event after TAVI Improvemtnt of NYHA classification and mean aortic gradient after TAVI |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who have aortic stenosis for which TAVI was considered in Keio University hospital. | |||
| Key exclusion criteria | The patients who are under 20 years old or who are deemed to be unfit as subjects of our survey. | |||
| Target sample size | 800 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Keio University Hospital | ||||||
| Division name | Cardiology | ||||||
| Zip code | |||||||
| Address | 35, Shinanomachi, Shinjyuku-ku, Tokyo, Japan | ||||||
| TEL | 03-3353-1211 | ||||||
| k-hayashida@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Keio University Hospital | ||||||
| Division name | Cardiology | ||||||
| Zip code | |||||||
| Address | 35, Shinanomachi, Shinjyuku-ku, Tokyo, Japan | ||||||
| TEL | 03-3353-1211 | ||||||
| Homepage URL | |||||||
| k-hayashida@umin.ac.jp | |||||||
| Sponsor | |
| Institute | Keio University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Toyohashi Heart Center
Teikyo University Hospital Shin-tokyo Hospital Kokura Memorial Hospital Sendai Kousei Hospital Shonan Kamakura Hospital Saiseikai Yokohamashi Tobu Hospital Ogaki Municipal Hospital Kishiwada Tokushukai Hospital Tokyo Bay Urayasu/Ichikawa Medical Center Osaka City University Hospital Toyama University Hospital Nagoya Heart Center |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | This study is a prospective, observational study, and will last about 6 years. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027271 |